SIMULTANEOUS DETERMINATION OF FELBAMATE, PRIMIDONE, PHENOBARBITAL, CARBAMAZEPINE, 2 CARBAMAZEPINE METABOLITES, PHENYTOIN, AND ONE PHENYTOINMETABOLITE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
La. Romanyshyn et al., SIMULTANEOUS DETERMINATION OF FELBAMATE, PRIMIDONE, PHENOBARBITAL, CARBAMAZEPINE, 2 CARBAMAZEPINE METABOLITES, PHENYTOIN, AND ONE PHENYTOINMETABOLITE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Therapeutic drug monitoring, 16(1), 1994, pp. 90-99
An isocratic liquid-chromatographic method employing one extraction st
ep has been developed for the quantitation of five drugs and three met
abolites in human plasma. The method uses 0.100-ml aliquots of human p
lasma and two internal standards. Chromatographic conditions include a
4.6 mm x 150 mm Spherisorb ODS2, 3 mu m a high-performance liquid chr
omatography, (HPLC) column, a phosphate buffer-acetonitrile-methanol (
700:160:140) mobile phase, and ultraviolet (UV) absorbance detection a
t 210 nm. Analytes and linear quantitation ranges (mu g/ml) were felba
mate (FBM) 0.398-200; primidone (PRIM), 0.09-100; phenobarbital (PHENO
), 0.195-100; carbamazepine (CBZ), 0.195-100; phenytoin (PHT), 0.195-2
00. For CBZ-transdiol (CBZ-TR) CBZ-epoxide (CBZ-EP), and the PHT metab
olite, 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH), the range was 0.0
49-25.0 mu g/ml. Ethosuximide, methsuximide, 2-methyl-2-phenyl-succini
mide (methsuximide metabolite), 2-ethyl-2-phenyl malonamide (PRIM meta
bolite, 5-ethyl-5-(4-hydroxyphenyl)-barbituric acid (PHENO metabolite)
, and mephenytoin do not interfere with quantitation of the above comp
ounds.